OPK

OPKO Health Inc. Common Stock

HealthcareDiagnostics & ResearchUnited StatesNASDAQ

$1.13

+0.00%today

MKT CAP

$853M

-5.0% · 1Y

Full Financials

Trailing P/E-

Forward P/E-3.5x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ-16.4%

5y Revenue CAGR-15.5%

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership49.6%

Institutional Ownership27.1%

Short % of Float7.72%

Days to Cover13.0d

1 Week-7.4%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
CSTL Castle Biosciences Inc. Common Stock	$748M	-	-	-	-	-	-	-	0.00%
WGS GeneDx Holdings Corp. Class A Common Stock	$998M	60	-	19.7	-	-	-	-	0.00%
CDNA CareDx Inc. Common Stock	$1.1B	60	-	18.3	-	-	-	-	0.00%
NEO NeoGenomics Inc. Common Stock	$1.2B	40	-	24.4	-	-	-	-	0.00%
PSNL Personalis Inc. Common Stock	$628M	-	-	-	-	-	-	-	0.00%
FLGT Fulgent Genetics Inc. Common Stock	$426M	-	-	-	-	-	-	-	0.00%